Skip to main content
Equibles

MORGAN STANLEY

Position in LYEL — Lyell Immunopharma, Inc.

CIK 895421 NEW YORK, NY
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$520,549
-$605,838 QoQ
Shares Held
37,050
-34.0% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. LYEL ranks #275 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in LYEL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $520,549 37,050
2026-03-31 $1,126,387 56,151
2025-12-31 $1,321,967 42,949
2025-09-30 $601,202 37,020
2025-06-30 $227,167 25,698
2025-03-31 $466,122 866,403
2024-12-31 $777,141 1,214,287
2024-09-30 $2,384,510 1,727,908
2024-06-30 $653,597 450,760
2024-03-31 $1,216,165 545,367
2023-12-31 $1,062,333 547,597
2023-09-30 $374,758 254,940
2023-06-30 $1,117,816 351,515
2023-03-31 $579,787 245,674
2022-12-31 $759,537 218,888
2022-09-30 $3,042,599 415,089
2022-06-30 $1,414,146 216,894
2022-03-31 $1,808,100 358,040
2021-12-31 $7,753,495 1,001,744
2021-09-30 $7,977,213 539,001
2021-06-30 $26,744,777 1,646,846